Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02704546Unknown
Randomised, double-blind trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Sheba Medical Center. Primary endpoints: Physiological strain at 2 days and Aerobic capacity at 2 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02704546.